Unlock unparalleled insights and elevate your expertise by learning from the industry’s leading experts. Don’t let this opportunity pass you by! NOVEMBER 19th, 2024 11:00 AM -12 PM (EST) Register Now https://lnkd.in/eadXnY6m #LumaCyte #CellAnalysis #MalvernPanalytical #Research #Innovation
LumaCyte
Pharmaceutical Manufacturing
Charlottesville, VA 3,235 followers
Transforming the status quo through rapid label-free single cell analysis
About us
LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary technology utilizes Laser Force Cytology™ (LFC™) to measure optical and fluidic forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell. The multivariate nature of the data has enabled a host of Big Data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell based biological systems. Applications of LumaCyte's label-free platform technology include viral infectivity for vaccine development and manufacturing, cell and gene therapy development and production monitoring, cancer biology R&D, CAR T-cell immunotherapy, iPSCs, infectious disease, and pre-clinical drug discovery, in addition to multiple applications across the biomanufacturing sector for improved production consistency and product quality. Innovate. Discover. Transform.
- Website
-
http://www.LumaCyte.com
External link for LumaCyte
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Charlottesville, VA
- Type
- Privately Held
- Founded
- 2012
- Specialties
- Cancer biology, Vaccine development, Rapid viral infectivity, Biomanufacturing, Bioprocess Monitoring , Oncolytic Virus, Cell Therapy, Gene Therapy, iPSCs, Vaccine R&D, Vaccine Production Monitoring, Label-free Single Cell Analysis, Biomarker Identification and Monitoring, CAR T , AAV Transfection Monitoring, T-cell Activation, CMC Production Quality, Transforming the Status Quo, and Rapid Viral Quantification
Locations
-
Primary
1145 River Rd
Charlottesville, VA 22901, US
Employees at LumaCyte
-
Renee A. Hart
President & CBO, LumaCyte Precision Cellular PAT Analytics | Label-Free Cell Viable State & Donor Characterization | Real-Time Production Monitoring…
-
Sean Hart, PhD
Chief Executive Officer & CSO, LumaCyte | Innovative Scientist and Entrepreneur | Analytical Expert | Biotechnology Professional
-
Justin Masters
Director, Customer Operations at LumaCyte
-
Sandra Walton
Senior Applications Scientist at LumaCyte Inc.
Updates
-
We are thrilled to see the enthusiasm our customers have for LumaCyte’s Radiance® platform cellular PAT. Your support and passion for our technology are invaluable to us. We are excited to work with each of you to advance innovative analytics into your workflows and accelerate the delivery of life saving products to patients who are waiting. Thank you for all you do to breakthrough the status quo!
-
LumaCyte Unveils Predictive CAR T Donor Analytics to Revolutionize Cell Therapy Manufacturing LumaCyte is proud to announce the launch of it’s groundbreaking cell therapy application for predictive CAR T donor analytics using their Laser Force Cytology™ (LFC™) technology and Radiance® instrument. This innovation provides deep insights into patient and donor cellular material, predicting manufacturing success and enhancing production consistency. LumaCyte now offers a new donor qualification service, allowing customers to send samples directly to LumaCyte for analysis, aiming to support the growing need for comprehensive cellular analysis and revolutionize cell therapy manufacturing efforts by minimizing risks and increasing product yields. Sign up today! https://lnkd.in/e4s-AKrs #LumaCyte #CellTherapy #CART #DonorAnalytics #LaserForceCytology #RadianceInstrument #BiotechInnovation #HealthcareRevolution #PredictiveAnalytics #CellManufacturing #MedicalBreakthrough #DonorQualification
-
We had an incredible experience connecting with everyone at the BioProcess International Conference in Boston! Thank you to all who stopped by our booth and attended our BioProcess Insider’s State of the Industry Discussion. We were thrilled to delve into the current global macroeconomic conditions, explore the future of biomanufacturing and Bioprocess 4.0, and examine the significant impacts of the evolving regulatory landscape. We look forward to continuing these discussions and collaborations. #BioProcess2024 #Biomanufacturing #Innovation #IndustryInsights #RegulatoryLandscape #FutureOfBiotech #Networking #BostonConference
-
Our team had an amazing time connecting with everyone at the PDA - Parenteral Drug Association BioManufacturing Conference 2024! Thank you to all who stopped by our booth and poster presentation. The conversations were filled with passion for innovation and a focus on the future of biomanufacturing. We look forward to continuing these discussions and collaborations. See you next year! #BioTech #BioManufacturing #PharmaInnovation #LifeSciences #PDAConference #PDABioManufacturing #BiotechCommunity #PharmaTech #IndustryLeaders #FutureOfMedicine
-
Join the LumaCyte team this week at the BioProcess International Conference in Boston! Don’t miss the BioProcess Insider’s State of the Industry Discussion: Date: September 25 Time:10:35 AM - 11:25 AM Location: Innovation and Community Stage (Exhibit Hall) Come by and say hello! We look forward to seeing you there. Booth 1619!
-
BioProcess Insider's State of the Industry Discussion – BPI Boston Biotech Week Join Dan Stanton, Managing Editor, Bioprocess International, Olivier Loeillot, CEO, Repligen; Renee A. Hart, President & Chief Business Officer, LumaCyte and Andrew B. Harmon, MBA, PMP®, Senior Consultant, Latham BioPharm Group next week at the BioProcess International Event in Boston. Location: Innovation Main Stage Date: Wednesday, September 25 Time: 10:35 - 11:25 AM Join us for an insightful industry discussion that delves into the current global macroeconomic conditions, explores the future of biomanufacturing and Bioprocess 4.0, and examines the significant impacts of the evolving regulatory landscape. This panel will provide a comprehensive overview of the challenges and opportunities facing the industry today, offering valuable perspectives from leading experts. Don’t miss this opportunity to stay informed and ahead of the curve in an ever-changing environment. #LumaCyte, #LaserForceCytology, #LFC, #CellAndGeneTherapy, #CGT, #cellfitness, #labelfree, #realtime, #precision, #analytics, #PAT, #processoptimization #bioprocess
-
Thank You for Joining Us! A huge thank you to everyone who attended Sean Hart, PhD’s talk on Quantitative Cell Characterization Using Laser Force Cytology™ (LFC): Predictive Insights into CAR T Donor Variability. It was amazing to see a standing room only crowd with so much excitement and interest in learning more about the power of LFC. If you haven’t had the chance yet, stop by Booth 81 to meet the LumaCyte team. We’re here for deep science discussions, and we’ve got some great swag waiting for you! See you there! #LumaCyte, #LaserForceCytology, #LFC, #CellAndGeneTherapy, #CGT, #cellfitness, #labelfree, #realtime, #precision, #analytics, #PAT, #processoptimization
-
Transform Your Workflow with Innovative Analytics! Advanced bioanalytics improve biomanufacturing efficiency, quality, and regulatory compliance, leading to safer and more effective biotherapeutics. https://lnkd.in/gJ-atKaM #PAT #PATanalytics #bioprocessing #dataanlytics
-
On this solemn anniversary, we honor the heroes we lost during the 9/11 attacks. Today, as we reflect on the profound emotions and memories, our hearts are with their families, friends, and loved ones. September 11, 2001, was a day of great loss, but it did not defeat our spirit. We stood strong in the face of tragedy, and we will always remember.